MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.020
+0.010 (0.98%)
Apr 29, 2026, 10:59 AM EDT - Market open
MIRA Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -10.44 | -7.85 | -11.98 | -7.06 | -2.18 | |
| Loss (Gain) From Sale of Investments | 0.04 | - | - | - | - | |
| Stock-Based Compensation | 6.31 | 1.92 | 2.55 | 1.3 | - | |
| Other Operating Activities | - | - | 5.54 | 0.01 | 0.02 | |
| Change in Accounts Payable | -0.59 | 0.18 | -0.39 | 0.15 | 0.78 | |
| Change in Other Net Operating Assets | 0.03 | 0.19 | -0.25 | -0.01 | - | |
| Operating Cash Flow | -4.66 | -5.56 | -4.53 | -5.6 | -1.38 | |
| Short-Term Debt Issued | 0.57 | - | 2.15 | - | 0.2 | |
| Total Debt Issued | 0.57 | - | 2.15 | - | 0.2 | |
| Short-Term Debt Repaid | - | - | -1.14 | -0.16 | - | |
| Total Debt Repaid | - | - | -1.14 | -0.16 | - | |
| Net Debt Issued (Repaid) | 0.57 | - | 1.01 | -0.16 | 0.2 | |
| Issuance of Common Stock | 7.9 | 3.61 | 7.7 | 2.9 | 4.51 | |
| Other Financing Activities | -0.29 | 0.18 | 0.07 | 0.4 | -0.53 | |
| Financing Cash Flow | 8.18 | 3.79 | 8.78 | 3.15 | 4.18 | |
| Net Cash Flow | 3.51 | -1.77 | 4.25 | -2.46 | 2.81 | |
| Levered Free Cash Flow | -0.81 | -2.72 | -5.46 | -3 | -0.66 | |
| Unlevered Free Cash Flow | -0.81 | -2.72 | -3.3 | -2.99 | -0.64 | |
| Change in Working Capital | -0.57 | 0.37 | -0.64 | 0.15 | 0.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.